# Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT00409708** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 142 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy
- **BEHAVIORAL:** Behavior Therapy

## Key facts

- **NCT ID:** NCT00409708
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-03
- **Final completion:** —
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00409708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00409708, "Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00409708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*